We are live on
!
Find out more
ASLN
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN
Delisted
ASLN was delisted on the 18th of July, 2024.
Fund managers haven’t disclosed any holdings of ASLN yet.
ASLN Hedge Fund Activity: Q1 2026 in Review
1 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q1 2026, worth a combined $17 — unchanged from a quarter earlier.
Fund positioning in ASLN was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 1 institutional investor held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $17 of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q1 2026, unchanged quarter-over-quarter.
- 0 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q1 2026 and 0 closed out.
Based on aggregated 13F filings for Q1 2026.